Requirement for efficient interactions between CD4 and MHC class II molecules for survival of resting CD4+ T lymphocytes in vivo and for activation-induced cell death

Journal of Immunology

Volumn 162, Issue 10, 1999, Pages 5973-5980

  Maroto, Rosario ^a   Shen, Xiaoli ^a   König, Rolf ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; FAS ANTIGEN; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN RECOGNITION; APOPTOSIS; ARTICLE; CELL DEATH; CELL SURVIVAL; CROSS LINKING; CYTOKINE PRODUCTION; GENE EXPRESSION; GENE MUTATION; HELPER CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE;

EID: 0033563146     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Teh, H.-S., P. Kisielow, B. Scott, H. Kishi, Y. Uematsu, H. Bluethmann, and H. von Boehmer. 1988. Thymic major histocompatibility antigens and the αβ T-cell receptor determine the CD4/CD8 phenotype of T cells. Nature 335:229.
2. Berg, L. J., A. M. Pullen, B. Fazekas de St. Groth, D. Mathis, C. Benoist, and M. M. Davis. 1989. Antigen/MHC-specific T cells are preferentially exported from the thymus in the presence of their MHC ligand. Cell 58:1035.
3. Aldrich, C. J., R. E. Hammer, S. Jones-Youngblood, U. Koszinowski, L. Hood, I. Stroynowski, and J. Forman. 1991. Negative and positive selection of antigen-specific cytotoxic T lymphocytes affected by the α3 domain of MHC I molecules. Nature 352:718.
4. Ingold, A. L., C. Landel, C. Knall, G. A. Evans, and T. A. Potter. 1991. Co-engagement of CD8 with the T cell receptor is required for negative selection. Nature 352:721.
5. Killeen, N., A. Moriarty, H. S. Teh, and D. R. Littman. 1992. Requirement for CD8-major histocompatibility complex class I interaction in positive and negative selection of developing T cells. J. Exp. Med. 176:89.
6. Engleman, E. G., C. J. Benike, F. C. Grumet, and R. L. Evans. 1981. Activation of human T lymphocyte subsets: helper and suppressor/cytotoxic T cells recognize and respond to distinct histocompatibility antigens. J. Immunol. 127:2124.
7. + human cytotoxic T cell clones directed at class I and class II MHC antigens. J. Immunol. 129:1563.
8. Bierer, B. E., B. P. Sleckman, S. E. Ratnofsky, and S. J. Burakoff. 1989. The biologic roles of CD2, CD4, and CD8 in T-cell activation. Annu. Rev. Immunol. 7:579.
9. Connolly, J. M., T. A. Potter, E. M. Wormstall, and T. H. Hansen. 1988. The Lyt-2 molecule recognizes residues in the class I α3 domain in allogeneic cytotoxic T cell responses. J. Exp. Med. 168:325.
10. Potter, T. A., T. V. Rajan, R. F. Dick, and J. A. Bluestone. 1989. Substitution at residue 227 of H-2 class I molecules abrogates recognition by CD8-dependent, but not CD8-independent, cytotoxic T lymphocytes. Nature 337:73.
11. Salter, R. D., R. J. Benjamin, P. K. Wesley, S. E. Buxton, T. P. J. Garrett, C. Clayberger, A. M. Krensky, A. M. Norment, D. R. Littman, and P. Parham. 1990. A binding site for the T-cell co-receptor CD8 on the α3 domain of HLA-A2. Nature 345:41.
12. König, R., L. Y. Huang, and R. N. Germain. 1992. MHC class II interaction with CD4 mediated by a region analogous to the MHC class I binding site for CD8. Nature 356:796.
13. König, R., X. Shen, and R. N. Germain. 1995. Involvement of both MHC class II α and β chains in CD4 function indicates a role for ordered oligomerization in T cell activation. J. Exp. Med. 182:779.
14. Connolly, J. M., T. H. Hansen, A. L. Ingold, and T. A. Potter. 1990. Recognition by CD8 on cytotoxic T lymphocytes is ablated by several substitutions in the class I α3 domain: CD8 and the T-cell receptor recognize the same class I molecule. Proc. Natl. Acad. Sci. USA 87:2137.
15. Janeway, C. A. 1992. The T cell receptor as a multicomponent signalling machine: CD4/CD8 coreceptors and CD45 in T cell activation. Annu. Rev. Immunol. 10:645.
16. Ravichandran, K. S., T. L. Collins, and S. J. Burakoff. 1996. CD4 and signal transduction. Curr. Top. Microbiol. Immunol. 205:47.
17. + T cells in vivo. Proc. Natl. Acad. Sci. USA 95:4493.
18. + T lymphocytes in transgenic mice expressing mutant MHC class II molecules deficient in their interaction with CD4. J. Immunol. 161:6629.
19. Boehme, S. A., L. Zheng, and M. J. Lenardo. 1995. Analysis of the CD4 coreceptor and activation-induced costimulatory molecules in antigen-mediated mature T lymphocyte death. J. Immunol. 155:1703.
20. Shen, X., and R. König. 1998. Regulation of T cell immunity and tolerance in vivo by CD4. Int. Immunol. 10:247.
21. Banda, N. K., J. Bernier, D. K. Kurahara, R. Kurrle, N. Haigwood, R. P. Sékaly, and T. H. Finkel. 1992. Cross-linking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis. J. .Exp. Med. 176:1099.
22. Oyaizu, N., T. W. McCloskey, M. Coronesi, N. Chirmule, V. S. Kalyanaraman, and S. Pahwa. 1993. Accelerated apoptosis in peripheral blood mononuclear cells (PBMCs) from human immunodeficiency virus type-1 infected patients and in CD4 cross-linked PBMCs from normal individuals. Blood 82:3392.
23. Wang, L., B. B. Gelman, R. König, and M. W. Cloyd. 1999. A novel mechanism of CD4 lymphocyte depletion involves HIV's effects on resting lymphocytes: induction of lymph node homing and apoptosis upon secondary signaling through homing receptors. J. Immunol. 162:268.
24. Algeciras, A., D. H. Dockrell, D. H. Lynch, and C. Paya. 1998. CD4 regulates susceptibility to Fas ligand- and tumor necrosis factor-mediated apoptosis. J .Exp. Med. 187:711.
25. Kouskoff, V., H. J. Fehling, M. Lemeur, C. Benoist, and D. Mathis. 1993. A vector driving the expression of foreign cDNAs in the MHC class II-positive cells of transgenic mice. J. Immunol. Methods 166:287.
26. + T lymphocytes in vitro and in vivo. J. Immunol. 157:87.
27. Schmid, I., W. J. Krall, C. H. Uittenbogaart, J. Braun, and J. V. Giorgi. 1992. Dead cell discrimination with 7-amino-actinomycin D in combination with dual color immunofluorescence in single laser flow cytometry. Cytometry 13:204.
28. Lecoeur, H., E. Ledru, M. C. Prevost, and M. L. Gougeon. 1997. Strategies for phenotyping apoptotic peripheral human lymphocytes comparing ISNT, annexin-V and 7-AAD cytofluorometric staining methods. J. Immunol. Methods 209:111.
29. + T cells in mice tolerant to Staphylococcus aureus enterotoxin B. Nature 349:245.
30. + T cells is regulated by the antigen-presenting cell. J. Immunol. 150:3832.
31. Huang, L., G. Soldevila, M. Leeker, R. A. Flavell, and I. N. Crispe. 1994. Liver is the site of T cell destruction during peripheral deletion. Immunity 1:741.
32. Vermes, I., C. Haanen, H. Steffens-Nakken, and C. Reutelingsperger. 1995. A novel assay for apoptosis: flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J. Immunol. Methods 184:39.
33. Verhoven, B., R. A. Schlegel, and P. Williamson. 1995. Mechanisms of phosphatidylserine exposure, a phagocyte recognition signal, on apoptotic T lymphocytes. J. Exp. Med. 182:1597.
34. Lenardo, M. J. 1991. Interleukin-2 programs mouse αβ T lymphocytes for apoptosis. Nature 353:858.
35. + T cells, but affect their long-term life span. Immunity 5:217.
36. 1/S transition to acquire susceptibility to Fas-mediated apoptosis. J. Immunol. 157:4309.
37. Zheng, L., C. L. Trageser, D. M. Willerford, and M. J. Lenardo. 1998. T cell growth cytokines cause the superinduction of molecules mediating antigen-induced T lymphocyte death. J. Immunol. 160:763.
38. Gougeon, M. L., H. Lecoeur, A. Dulioust, M. G. Enouf, M. Crouvoiser, C. Goujard, T. Debord, and L. Montagnier. 1996. Programmed cell death in peripheral lymphocytes from HIV-infected persons: increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and with disease progression. J. Immunol. 156:3509.
39. Gonzalez-Garcia, A., I. Merida, A. C. Martinez, and A. C. Carrera. 1997. Intermediate affinity interleukin-2 receptor mediates survival via a phosphatidylinositol 3-kinase-dependent pathway. J. Biol. Chem. 272:10220.
40. Gougeon, M. L., H. Lecoeur, F. Boudet, E. Ledru, S. Marzabal, S. Boullier, R. Roue, S. Nagata, and J. Heeney. 1997. Lack of chronic immune activation in HIV-infected chimpanzees correlates with the resistance of T cells to Fas/Apo-1 (CD95)-induced apoptosis and preservation of a T helper 1 phenotype. J. Immunol. 158:2964.
41. Radvanyi, L. G., K. Raju, D. Spaner, G. B. Mills, and R. G. Miller. 1998. Inlerleukin-2 reverses the defect in activation-induced apoptosis in T cells from autoimmune lpr mice. Cell. Immunol. 183:1.
42. Nagata, S., and P. Golstein. 1995. The Fas death factor. Science 267:1449.
43. Van Parijs, L., A. Ibraghimov, and A. K. Abbas. 1996. The roles of costimulation and Fas in T cell apoptosis and peripheral tolerance. Immunity 4:321.
44. Beutner, U., and H. R. MacDonald. 1998. TCR-MHC class II interaction is required for peripheral expansion of CD4 cells in a T cell-deficient host. Int. Immunol. 10:305.
45. Rooke, R., C. Waltzinger, C. Benoist, and D. Mathis. 1997. Targeted complementation of MHC class II deficiency by intrathymic delivery of recombinant adenoviruses. Immunity 7:123.